基本信息
views: 38
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
致力于营养、环境等因素所致代谢性疾病的病理机制和治疗策略研究,围绕“代谢性疾病中的线粒体稳态失衡”这一关键科学问题,开展新病理机制、新靶标论证和新分子实体发现等研究。近五年来以通讯作者于Cell Metabolism(2021)、 Kidney International(2022)、Acta Pharmaceutica Sinica B (2022)、Diabetes(2019a;2019b; 2021)、Cell Death & Disease(2019;2020)和Frontiers in Physiology(2018)等刊物发表学术论文十余篇;所有论文他引近3700次,H-index为30。基于线粒体稳态调控发现多个候选新药,其中家族性高胆固醇血症候选药物BGT-002获批临床试验(批准号2022LP00213)。相关应用研究成果申请国内外发明专利15项,已获授权发明专利4项。
Research Interests
Papers共 240 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF MEDICINAL CHEMISTRYno. 10 (2024): 7870-7890
SCIENCE TRANSLATIONAL MEDICINEno. 733 (2024): eade8647-eade8647
Fitoterapia (2024): 105813-105813
Chinese Journal of Chemistry (2024)
Xueran Zhu, Shumin Cui, Xinjing Liu, Mei Zhang,Zhifu Xie, Wei Li,Jingya Li,Fajun Nan,Yangming Zhang,Yan Zhan,Xiaoyan Chen
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2024): 116056-116056
Science advancesno. 6 (2024): eadj2752-eadj2752
Bioorganic chemistry (2023): 106381-106381
Xiangrong Kong,Wei Liu,Xinwen Zhang,Chendong Zhou,Xinyu Sun, Long Cheng,Jinxia Lin,Zhifu Xie,Jingya Li
Load More
Author Statistics
#Papers: 244
#Citation: 7283
H-Index: 39
G-Index: 77
Sociability: 7
Diversity: 0
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn